NLRP3 and infection: In agreement, WT Caco-2 cells pretreated with a chemical inhibitor of the NLRP3 inflammasome, MCC950, underwent comparable levels of inflammasome activation in response to Δ6 Yptb infection as infected vehicle control-treated Caco-2 cells (Fig. S4A).